/
بحث بيانات أعضاء هيئة التدريس - جامعة الزقازيق
بحث بيانات أعضاء هيئة التدريس
facebook
youtube
googleplus
twitter
zagazig
En
الموقع الشخصى
السيرة الذاتية
علي محمد عبدالرحمن على سعد
الكلية الطب - القسم طب القلب والاوعية الدموية
الدرجات العلمية
بكالوريوس فى الطب والجراحه, -جامعة الزقازيق [1980]
ماجستير فى طب القلب والاوعيه الدمويه, -جامعة الزقازيق [1986]
دكتوراه فى طب القلب والاوعيه الدمويه, -جامعة الزقازيق [1992]
الحالة الوظيفية الحالية :
قائم بالعمل
التدرج الوظيفى الأكاديمى
معيد : 1/1/1900
مدرس مساعد : 9/6/1987
مدرس : 24/8/1992
أستاذ مساعد : 26/8/1997
أستاذ : 29/10/2002
استاذ متفرغ : 1/8/2014
الأبحاث العلمية
1 -
The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe The Euro Heart Survey on diabetes and the heart (1424).
2 -
Treatment and Health Status in Patients with Proven Coronary Artery Disease, but Ineligible for Revascularization. A Report from the Euro Heart Survey on Revascularization (1426).
3 -
Pharmacological treatment and perceived health status during 1-year follow up in patients diagnosed with coronary artery disease, but ineligible for revascularization: Results from the Euro Heart Survey on coronary revascularization (1426).
4 -
A 1-year follow up in patients diagnosed with coronary artery disease, but ineligible for revascularization. Results from The Euro Heart Survey on Coronary Revascularization (1426).
5 -
Atrial fibrillation management: a prospective survey in ESC Member Countries (1425).
6 -
Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation (1429).
7 -
EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population (1427).
8 -
Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization (1426).
9 -
An insight into the current use of drug eluting stents in acute and elective percutaneous coronary interventions in Europe A report on the EuroPCI Survey (1428).
10 -
Quality of Life in Patients With Established Coronary Heart Disease: Results from the Euro Heart Survey on Coronary Revascularization (EHS-CR) (1424).
11 -
Abnormal glucose regulation in patients with coronary artery disease across Europe (1424).
12 -
Caracteristiques cliniques et therapeutique des insuffisants cardiaques de plus de 80 ans: resultats de l'etude Euro Heart Failure Survey (1425).
13 -
Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: results from the Euro Heart Survey on Coronary Revascularization (1426).
14 -
Diabetes does not influence treatment decisions regarding revascularization in patients with stable coronary artery disease (1430).
15 -
Treatment decisions in stable coronary artery disease: Insights from the Euro Heart Survey on Coronary Revascularization (1426).
16 -
Pulmonary hypertension and pregnancy outcomes: data from the Registry Of Pregnancy and Cardiac Disease (ROPAC) of the European Society of Cardiology (1438).
17 -
Current use of cardiac magnetic resonance in tertiary referral centres for the diagnosis of cardiomyopathy: the ESC EORP Cardiomyopathy/Myocarditis Registry (1442).
18 -
Pregnancy outcome in thoracic aortic disease data from the Registry Of Pregnancy And Cardiac disease (1442).
19 -
Pregnancy outcomes in women after arterial switch operation for transposition of the great arteries: results from ROPAC (Registry of Pregnancy and Cardiac Disease) of the … (1442).
20 -
Electrocardiographic features and their echocardiographic correlates in peripartum cardiomyopathy: results from the ESC EORP PPCM registry (1442).
21 -
A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey (1431).
22 -
Gender-Related Differences in Presentation, Treatment, and Outcome of Patients With Atrial Fibrillation in Europe: A Report From the Euro Heart Survey on Atrial Fibrillation (1428).
23 -
Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the … (1427).
24 -
Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study (1441).
25 -
Glucose lowering treatment in patients with coronary artery disease is prognostically important not only in established but also in newly detected diabetes mellitus: a report … (1428).
26 -
International Prospective Registry of Acute Coronary Syndromes in Patients With COVID-19 (1442).
27 -
Reperfusion strategy in Europe: temporal trends in performance measures for reperfusion therapy in ST-elevation myocardial infarction (1431).
28 -
Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart … (1430).
29 -
Pregnancy outcomes in women with rheumatic mitral valve disease: results from the registry of pregnancy and cardiac disease (1439).
30 -
Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey (1433).
31 -
Global cardiac risk assessment in the Registry Of Pregnancy And Cardiac disease: results of a registry from the European Society of Cardiology (1437).
32 -
Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation: data from the Euro Heart Survey (1429).
33 -
Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on … (1429).
34 -
Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure (1431).
35 -
Management of coronary artery disease in patients with and without diabetes mellitus. Acute management reasonable but secondary prevention unacceptably poor: a report from the … (1428).
36 -
Congenital heart disease in the ESC EORP Registry of Pregnancy and Cardiac disease (ROPAC) (1442).
37 -
Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC Peripartum Cardiomyopathy Registry (1442).
38 -
Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial … (1431).
39 -
Progression from paroxysmal to persistent atrial fibrillation: clinical correlates and prognosis (1431).
40 -
Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation (1427).
41 -
Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II (1430).
42 -
Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart … (1428).
43 -
Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization (1426).
44 -
Pregnancy in women with a mechanical heart valve: data of the European Society of Cardiology Registry of Pregnancy and Cardiac Disease (ROPAC) (1436).
45 -
Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on … (1427).
46 -
Gender related differences in patients presenting with acute heart failure. Results from EuroHeart Failure Survey II (1429).
47 -
Pregnancy outcomes in women with cardiovascular disease: evolving trends over 10 years in the ESC Registry Of Pregnancy And Cardiac disease (ROPAC) (1440).
48 -
Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation? (1429).
49 -
Use and impact of intra-aortic balloon pump on mortality in patients with acute myocardial infarction complicated by cardiogenic shock: results of the Euro Heart Survey on PCI (1432).
50 -
The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry (1440).
51 -
Resting heart rate in patients with stable coronary artery disease and diabetes: a report from the Euro Heart Survey on Diabetes and the Heart (1431).
52 -
Increased burden of comorbidities and risk of cardiovascular death in atrial fibrillation patients in Europe over ten years: A comparison between EORP-AF pilot and EHS-AF registries (1439).
53 -
Ventricular tachyarrhythmia during pregnancy in women with heart disease: Data from the ROPAC, a registry from the European Society of Cardiology (1437).
54 -
The additional value of patient-reported health status in predicting 1-year mortality after invasive coronary procedures: a report from the Euro Heart Survey on Coronary … (1428).
55 -
Pregnant women with uncorrected congenital heart disease: heart failure and mortality (1441).
56 -
The influence of progression of atrial fibrillation on quality of life: a report from the Euro Heart Survey (1438).
57 -
Symptomatic atrial fibrillation and risk of cardiovascular events: data from the Euro Heart Survey (1438).
58 -
Fate of patients with coronary perforation complicating percutaneous coronary intervention (from the Euro Heart Survey Percutaneous Coronary Intervention Registry) (1437).
59 -
Prima-vista multi-vessel percutaneous coronary intervention in haemodynamically stable patients with acute coronary syndromes: Analysis of over 4.400 patients in the EHS-PCI registry (1434).
60 -
ESC EORP Cardiomyopathy Registry: real‐life practice of genetic counselling and testing in adult cardiomyopathy patients (1442).
61 -
Assessment of interatrial dyssynchrony by Tissue Doppler Imaging in mitral stenosis: Effect of afterload reduction after balloon mitral valvuloplasty (1437).
62 -
THE ROLE OF MONOCYTE CHEMOATTRACTANT PROTEIN-1 IN DIAGNOSIS OF ISCHEMIC HEART DISEASE WITH NEGATIVE EXERCISE (1440).
63 -
Interventional treatment in diabetics in the era of drug-eluting stents and compliance to the ESC guidelines: lessons learned from the Euro Heart Survey Programme. (1430).
64 -
Infective endocarditis in the Netherlands: current epidemiological profile and mortality: an analysis based on partial ESC EORP collected data (1442).
65 -
Incidence and outcome of peri-procedural cardiogenic shock: results from the international Euro Heart Survey PCI registry (1441).
66 -
Value of Killip classification first described in 1,967 for risk stratification of stemi and Nste-Acs in the new Millennium: Lessons from the euro heart survey ACS registry (1432).
67 -
Progression From Paroxysmal to Persistent Atrial Fibrillation. Clinical Correlates and Prognosis (1431).
68 -
Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019 (1444).
69 -
The burden of metabolic risk factors in North Africa and the Middle East, 1990-2019: findings from the Global Burden of Disease Study (1444).
70 -
Cardiac device-related infective endocarditis need for lead extraction whatever the device according to the ESC EORP EURO-ENDO registry (1444).
71 -
Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021 (1445).
72 -
Global burden of peripheral artery disease and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 (1444).
73 -
Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021 (1445).
74 -
Sex-specific presentation, care, and clinical events in individuals admitted with NSTEMI: the ACVC-EAPCI EORP NSTEMI registry of the European Society of Cardiology (1445).
75 -
Rationale and design of the ESC Heart Failure III Registry – Implementation and discovery (1445).
76 -
Drug-use disorders in the Eastern Mediterranean Region: a glance at GBD 2019 findings (1445).
77 -
Factors determining utility measured with the EQ-5D in patients with atrial fibrillation (1431).
78 -
Incidence and Clinical Impact of Stroke Complicating Percutaneous Coronary Intervention (1434).
79 -
EuroHeart score for the evaluation of in-hospital mortality in patients undergoing percutaneous coronary intervention (1432).
80 -
Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation (1434).
81 -
Dual antiplatelet therapy duration after coronary stenting in clinical practice: results of an EAPCI survey (1436).
82 -
Stroke and Bleeding Risk Co-distribution in Real-world Patients with Atrial Fibrillation: The Euro Heart Survey (1435).
83 -
Acute Coronary Syndrome and Ischemic Heart Disease in Pregnancy: Data From the EURObservational Research Programme‐European Society of Cardiology Registry of Pregnancy and Cardiac Disease (1441).
84 -
Effect of systemic hypertension with versus without left ventricular hypertrophy on the progression of atrial fibrillation (from the Euro Heart Survey) (1439).
85 -
Effect of systemic hypertension with versus without left ventricular hypertrophy on the progression of atrial fibrillation (from the Euro Heart Survey) (1439).
86 -
Predictive value of Neutrophil-Gelatinase-Associated Lipocalin on the Severity of coronary artery diseases and development of Contrast-Induced Nephropathy after Percutaneous … (1443).
87 -
Value of QRS distortion and ST-segment shift in acute coronary syndrome patients in relation to gensini score (1441).
88 -
CULPRIT VERSUS CULPRIT AND NON- CULPRIT PRIMARY CORONARY REVASCULARIZATION (1435).
89 -
Idiopathic atrial fibrillation revisited in a large longitudinal clinical cohort (1433).
90 -
Impact of diabetes mellitus status on coronary pathoanatomy and interventional treatment: Insights from the Euro heart survey PCI registry (1432).
91 -
Influence of socioeconomic factors on pregnancy outcome in women with structural heart disease (1439).
92 -
Use and outcome of thrombus aspiration in patients with primary PCI for acute ST-elevation myocardial infarction: results from the multinational Euro Heart Survey PCI Registry (1436).
93 -
Assessing the cardiology community position on transradial intervention and the use of bivalirudin in patients with acute coronary syndrome undergoing invasive management: results of an EAPCI survey. (1440).
94 -
Multivessel percutaneous coronary intervention in patients with stable angina: a common approach? Lessons learned from the EHS PCI registry (1433).
95 -
Infective endocarditis in the Netherlands: current epidemiological profile and mortality: an analysis based on partial ESC EORP collected data S El Kadi, DMF van den Buijs, T Meijers, MD Gilbers, S Bekkers, ... Netherlands Heart Journal 28, 526-536, 2020 (1434).
96 -
Infective endocarditis in adult patients with congenital heart disease (1444).
97 -
Socioeconomic variations determine the clinical presentation, aetiology, and outcome of infective endocarditis: a prospective cohort study from the ESC-EORP EURO-ENDO (European Infective Endocarditis) registry (1444).
98 -
Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry (1444).
99 -
ARTICLE Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry (1444).
100 -
Use of cardiac imaging in chronic coronary syndromes: the EURECA Imaging registry (1444).
101 -
Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026 (1444).
102 -
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 (1444).
103 -
Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019 (1445).
104 -
Presentation, care, and outcomes of patients with NSTEMI according to World Bank country income classification: the ACVC-EAPCI EORP NSTEMI Registry of the European Society of Cardiology (1444).
105 -
Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019 (1445).
106 -
Outcomes at one year in women with peripartum cardiomyopathy: Findings from the ESC EORP PPCM Registry (1445).
107 -
Predictors of embolism and death in left-sided infective endocarditis: the European Society of Cardiology EURObservational Research Programme European Infective Endocarditis registry (1445).
108 -
Global burden of cardiovascular diseases and risks, 1990-2022 (1445).
109 -
Unlocking the Prognostic Potential of Right Ventricular Strain in Heart Failure Subtypes (1447).
110 -
Global, regional, and national prevalence of kidney failure with replacement therapy and associated aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023 (1447).
111 -
Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 (1447).
112 -
Global, regional, and national sepsis incidence and mortality, 1990–2021: a systematic analysis (1447).
113 -
Changing life expectancy in European countries 1990–2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021 (1446).
114 -
Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 202 (1446).
115 -
Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study (1446).
116 -
The global, regional, and national burden attributable to low bone mineral density, 1990–2020: an analysis of a modifiable risk factor from the Global Burden of Disease Study 2021 (1447).
117 -
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 (1447).
118 -
Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023 (1447).
119 -
Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021 (1446).
120 -
Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021 (1446).
121 -
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 (1445).
122 -
Infective Endocarditis in Belgium: Prospective Data in Adults from the ESC EORP European Endocarditis Registry (1445).
123 -
Burden of disease scenarios by state in the USA, 2022–50: a forecasting analysis for the Global Burden of Disease Study 2021 (1446).
124 -
The burden of diseases, injuries, and risk factors by state in the USA, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 (1446).
125 -
Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 (1446).
126 -
Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 (1445).
127 -
Sex-specific presentation, care, and clinical events in individuals admitted with NSTEMI: the ACVC-EAPCI EORP NSTEMI registry of the European Society of Cardiology (1445).
128 -
The burden of neurological conditions in north Africa and the Middle East, 1990–2019: a systematic analysis of the Global Burden of Disease Study 2019 (1445).
129 -
Drug-use disorders in the Eastern Mediterranean Region: a glance at GBD 2019 findings (1447).
130 -
Global, regional, and national burden of gout, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021 (1446).
131 -
Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 (1446).
132 -
Global, regional, and national stillbirths at 20 weeks' gestation or longer in 204 countries and territories, 1990–2021: findings from the Global Burden of Disease Study 2021 (1446).
133 -
Diabetes mellitus and presentation, care and outcomes of patients with NSTEMI: the Association for Acute Cardiovascular Care-European Association of Percutaneous Cardiovascular … (1445).
134 -
Heart failure in Europe: Guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction – the ESC EORP Heart Failure III Registry (1446).
135 -
Outcomes at one year in women with peripartum cardiomyopathy: Findings from the ESC EORP PPCM Registry (1445).
136 -
Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021 (1446).
137 -
Pregnancy outcomes in women with aortic coarctation (1442).
138 -
Pregnancy in Tetralogy of Fallot Data from the ESC EORP ROPAC registry (1442).
139 -
Clinical presentation, management, and6-month outcomes in women with peripartumcardiomyopathy: an ESC EORP registry (1442).
140 -
Prospective follow-up in various subtypes of cardiomyopathies: insights from the ESC EORP Cardiomyopathy Registry (1442).
141 -
Acute Coronary Syndrome and Ischemic Heart Disease in Pregnancy: Data From the EURObservational Research Programme‐European Society of Cardiology Registry of Pregnancy and Cardiac Disease (1442).
142 -
Atrial fibrillation, anticoagulation management and risk of stroke in the Cardiomyopathy/Myocarditis registry of the EURObservational Research Programme of the European Society … (1442).
143 -
ESC EORP Cardiomyopathy Registry: real‐life practice of genetic counselling and testing in adult cardiomyopathy patients (1441).
144 -
Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry (1442).
145 -
Predictive Value of N-Terminal Pro B-Type Natriuretic Peptide for Poor Outcomes in Heart Failure Patients: A Stratified Analysis Based on Ejection Fraction (1446).
146 -
Global, regional, and national burden of pulmonary arterial hypertension, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 (1446).
147 -
Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019 (1446).
148 -
Predictive Value of N-Terminal Pro B-Type Natriuretic Peptide for Poor Outcomes in Heart Failure Patients: A Stratified Analysis Based on Ejection Fraction (1446).
149 -
Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage The Global Burden of Disease Study 2021 (1446).
150 -
Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023 (1447).
151 -
Global burden of vision impairment due to age-related macular degeneration, 1990–2021, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021 (1447).
152 -
Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023 (1447).
153 -
Mortality and disability-adjusted life years in North Africa and Middle East attributed to kidney dysfunction: a systematic analysis for the Global Burden of Disease Study 2019 (1445).
154 -
Cohort profile: the ESC EURObservational Research Programme Atrial Fibrillation III (AF III) Registry (1442).
155 -
Pregnancy outcomes in women with a systemic right ventricle and transposition of the great arteries results from the ESC-EORP Registry of Pregnancy and Cardiac disease (ROPAC) (1443).
156 -
Outcomes of culture-negative vs. culture-positive infective endocarditis: the ESC-EORP EURO-ENDO registry: clinical research (1443).
157 -
Adolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019 (1444).
158 -
Clinical profile and outcome of recurrent infective endocarditis (1444).
159 -
Characteristics, management, and outcomes of patients with left-sided infective endocarditis complicated by heart failure: a substudy of the ESC-EORP EURO-ENDO (European infective endocarditis) registry (1443).
160 -
Surgery and outcome of infective endocarditis in octogenarians: prospective data from the ESC EORP EURO-ENDO registry (1443).
161 -
Hypertensive disorders of pregnant women with heart disease: the ESC EORP ROPAC Registry (1443).
162 -
Risk of Pregnancy in Moderate and Severe Aortic Stenosis: From the Multinational ROPAC Registry (1438).
163 -
Sex-related aspects on abnormal glucose regulation in patients with coronary artery disease (1428).
164 -
Characteristics, management and prognosis of elderly patients in the Euro Heart Survey on atrial fibrillation (1434).
165 -
Predictive value of Neutrophil-Gelatinase-Associated Lipocalin on the Severity of coronary artery diseases and development of Contrast-Induced Nephropathy after Percutaneous … (1443).
166 -
Incidence and predictors of obstetric and fetal complications in women with structural heart disease (1439).
167 -
Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the … (1427).
168 -
Pregnancy Outcomes in Women With Rheumatic Mitral Valve Disease (1439).
169 -
Glucose lowering treatment in patients with coronary artery disease is prognostically important not only in established but also in newly detected diabetes mellitus: a report from the Euro Heart Survey on Diabetes and the Heart (1428).
170 -
Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study (1441).
171 -
Global cardiac risk assessment in the Registry Of Pregnancy And Cardiac disease: results of a registry from the European Society of Cardiology (1437).
172 -
Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey (1433).
173 -
Reperfusion strategy in Europe: temporal trends in performance measures for reperfusion therapy in ST-elevation myocardial infarction (1431).
174 -
The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathies (1439).
175 -
Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart (1429).
176 -
Predictors of hospital mortality in the elderly undergoing percutaneous coronary intervention for acute coronary syndromes and stable angina (1431).
177 -
Euro Heart Survey 2009 Snapshot: regional variations in presentation and management of patients with AMI in 47 countries (1435).
178 -
Pregnancy in women with hypertrophic cardiomyopathy: data from the European Society of Cardiology initiated Registry of Pregnancy and Cardiac disease (ROPAC) (1438).
179 -
Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation? (1429).
180 -
Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation: data from the Euro Heart Survey (1429).
181 -
Use and Outcomes of Multivessel Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock (from the EHS-PCI Registry) (1433).
182 -
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 (1446).
183 -
Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 (1446).
184 -
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 (1445).
185 -
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 (1445).
186 -
Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 (1445).
187 -
Global pattern, trend, and cross-country inequality of early musculoskeletal disorders from 1990 to 2019, with projection from 2020 to 2050 (1446).
المجالات البحثية
Atrial Fibrillation
Hypertension- Pulmonary Hypertension
- Pumonary Hypertention- Hypertention
Atrial Fibrillation
Cardiac Arrythmias
Cardiac catheterization
Cardiac genetics
جامعة المنصورة
جامعة الاسكندرية
جامعة القاهرة
جامعة سوهاج
جامعة الفيوم
جامعة بنها
جامعة دمياط
جامعة بورسعيد
جامعة حلوان
جامعة السويس
جامعة المنيا
جامعة دمنهور
جامعة المنوفية
جامعة أسوان
جامعة جنوب الوادى
جامعة قناة السويس
جامعة عين شمس
جامعة أسيوط
شراقوة | الشرقية بين ايديك
اخبار الشرقية - شراقوة | الشرقية بين ايديك
جامعة كفر الشيخ
جامعة السادات
جامعة طنطا
جامعة بنى سويف
